Fortescue Ltd
FMG
Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
Telstra Group Ltd
TLS
BHP Group Ltd
BHP
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.